CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
July 29, 2022—The FDA has cleared the BioMérieux Vidas Nephrocheck assay, for use to detect kidney stress in patients at risk of acute kidney injury.
Pages: 1 2
July 29, 2022—The FDA has cleared the BioMérieux Vidas Nephrocheck assay, for use to detect kidney stress in patients at risk of acute kidney injury.
Tagged with: BioMerieux